Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Money symbols : Lly save search
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.27%
H: 2.04%
C: 2.02%
corporation series treatment study
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
Published: 2023-11-13 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.26%
H: 4.11%
C: 3.09%
genetic series
Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer
Published: 2023-07-11 (Crawled : 13:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.7%
H: 0.12%
C: -2.36%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
antibody t-cell cancer treat therapeutics
Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
Published: 2023-06-06 (Crawled : 09:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.8%
H: 0.23%
C: -1.06%
zb-106 potential
Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases
Published: 2023-05-15 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.22%
H: 0.14%
C: -0.2%
neurological
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 2.68%
H: 4.62%
C: 3.89%
UTHR | $236.93 0.69% 0.78% 480K
|
Health Technology
|
| O: -3.84%
H: 1.83%
C: -0.73%
corporation therapeutics financial results
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
Published: 2023-04-17 (Crawled : 11:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.47%
H: 0.01%
C: -0.38%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.07%
H: 0.24%
C: -0.71%
financial
Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million
Published: 2022-11-28 (Crawled : 17:00) - biospace.com/
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.78%
H: 1.0%
C: -0.34%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.49%
H: 1.67%
C: 0.64%
therapeutics
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
Published: 2022-11-02 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.45%
H: 2.54%
C: 0.23%
UTHR | $236.93 0.69% 0.78% 480K
|
Health Technology
|
| O: 3.34%
H: 9.82%
C: 7.47%
therapeutics corporation financial results
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
Published: 2022-11-01 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
financial results
Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
Published: 2022-09-14 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.24%
H: 1.5%
C: 0.78%
therapeutics promise
Sanofi Stays Strong in Q2 as Dupixent thrives. Launches HBCU Diversity Partnership
Published: 2022-07-28 (Crawled : 16:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
partnership dupixent sanofi
Lilly plans to invest $2.1 billion in new manufacturing sites in Indiana
Published: 2022-05-25 (Crawled : 20:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.34%
H: 1.11%
C: 0.0%
Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund
Published: 2022-04-04 (Crawled : 11:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.03%
H: 0.76%
C: -0.45%
therapeutics
Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund
Published: 2022-04-04 (Crawled : 11:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.03%
H: 0.76%
C: -0.45%
TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases
Published: 2022-03-08 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
treatment disease trex media
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
UTHR | $236.93 0.69% 0.78% 480K
|
Health Technology
|
| O: -9.35%
H: 2.74%
C: -4.19%
financial results therapeutics corporation report results
Arkuda Reels in Another $64M to Disrupt Neurodegenerative Disease Treatment
Published: 2022-02-10 (Crawled : 19:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
treatment disease neurodegenerative
Lilly announces $1 billion investment in new manufacturing facility in North Carolina
Published: 2022-01-28 (Crawled : 19:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.33%
H: 3.25%
C: 3.2%
ces
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.